Form 8-K - Current report:
SEC Accession No. 0001193125-21-191664
Filing Date
2021-06-16
Accepted
2021-06-16 07:43:01
Documents
15
Period of Report
2021-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d187177d8k.htm   iXBRL 8-K 31114
2 EX-99.1 d187177dex991.htm EX-99.1 20490
6 GRAPHIC g187177g0615225326650.jpg GRAPHIC 3240
7 GRAPHIC g187177g0615225326869.jpg GRAPHIC 2687
  Complete submission text file 0001193125-21-191664.txt   195141

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zlab-20210615.xsd EX-101.SCH 3051
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zlab-20210615_lab.xml EX-101.LAB 18839
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zlab-20210615_pre.xml EX-101.PRE 11826
8 EXTRACTED XBRL INSTANCE DOCUMENT d187177d8k_htm.xml XML 3561
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 211020498
SIC: 2834 Pharmaceutical Preparations